Gerry Hanna

Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases

Shankar Siva, Gavin Jones, Mathias Bressel, Mark Shaw, Sarat Chander, Julie Chu, Nikki Plumridge, Keelan Byrne, Gargi Kothari, Nicholas Hardcastle, Mathieu Gaudreault, Tomas Kron, Greg Wheeler, Michael MacManus, Gerard G Hanna, David L Ball, Steven David

Journal article  |  2022  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE: Medical operability is prognostic for survival after SABR in primary malignancies. This study investigated the prognostic..

Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective

Nicholas W Bucknell, Jose Belderbos, David A Palma, Puneeth Iyengar, Pamela Samson, Kevin Chua, Daniel Gomez, Fiona McDonald, Alexander Louie, Corinne Faivre-Finn, Gerard G Hanna, Shankar Siva

Journal article  |  2022  |  JOURNAL OF THORACIC ONCOLOGY

Toxicity concerns from thoracic radiation therapy in the treatment of lung cancers have changed substantially over the past few de..

The impact of inter-observer variation in delineation on robustness of radiomics features in non-small cell lung cancer

Gargi Kothari, Beverley Woon, Cameron J Patrick, James Korte, Leonard Wee, Gerard G Hanna, Tomas Kron, Nicholas Hardcastle, Shankar Siva

Journal article  |  2022  |  SCIENTIFIC REPORTS

Artificial intelligence and radiomics have the potential to revolutionise cancer prognostication and personalised treatment. Manua..

Impact of operability and total metastatic ablation on outcomes after SABR for oligometastases

S Siva, M Bressel, P Sogono, M Shaw, S Chander, J Chu, N Plumridge, K Byrne, G Kothari, N Bucknell, N Hardcastle, T Kron, G Wheeler, M MacManus, GG Hanna, DL Ball, S David

Conference Proceedings  |  2022  |  RADIOTHERAPY AND ONCOLOGY

A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC)

Katherine Lee, Tue Le, Eric Hau, Gerard G Hanna, Harriet Gee, Shalini Vinod, Salma Dammak, David Palma, Anselm Ong, Roland Yeghiaian-Alvandi, Jacqueline Buck, Rebecca Lim

Journal article  |  2022  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE: Posttreatment surveillance for local recurrence (LR) after stereotactic ablative body radiotherapy (SABR) can include bot..

Utility of Biology-Guided Radiotherapy to De Novo Metastases Diagnosed During Staging of High-Risk Biopsy-Proven Prostate Cancer

Mathieu Gaudreault, David Chang, Nicholas Hardcastle, Price Jackson, Tomas Kron, Gerard G Hanna, Michael S Hofman, Shankar Siva

Journal article  |  2022  |  FRONTIERS IN ONCOLOGY

BACKGROUND: Biology-guided radiotherapy (BgRT) uses real-time functional imaging to guide radiation therapy treatment. Positron em..

Imaging immunity in patients with cancer using positron emission tomography

Fiona Hegi-Johnson, Stacey Rudd, Rodney J Hicks, Dirk De Ruysscher, Joseph A Trapani, Thomas John, Paul Donnelly, Benjamin Blyth, Gerard Hanna, Sarah Everitt, Peter Roselt, Michael P MacManus

Journal article  |  2022  |  NPJ PRECISION ONCOLOGY

Immune checkpoint inhibitors and related molecules can achieve tumour regression, and even prolonged survival, for a subset of can..

Disparities in radiation therapy utilization for cancer patients in Victoria

Wee Loon Ong, Norah Finn, Luc Te Marvelde, Colin Hornby, Roger L Milne, Gerard G Hanna, Graham Pitson, Hany Elsaleh, Jeremy L Millar, Farshad Foroudi

Journal article  |  2022  |  JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

INTRODUCTION: To evaluate the proportion of cancer patients who received radiation therapy (RT) within 12 months of cancer diagnos..

Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review

GM Walls, SOS Osman, KH Brown, KT Butterworth, GG Hanna, AR Hounsell, CK McGarry, RTH Leijenaar, P Lambin, AJ Cole, S Jain

Journal article  |  2022  |  CLINICAL ONCOLOGY

Lung cancer's radiomic phenotype may potentially inform clinical decision-making with respect to radical radiotherapy. At present ..

CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? reply

Dean A Fennell, Gareth Griffiths, Christian Ottensmeier, Gerard G Hanna, Sarah Danson, Peter Szlosarek, Mavis Nye

Journal article  |  2022  |  LANCET ONCOLOGY